Your browser doesn't support javascript.
loading
Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse.
Bein, Julia; Thurner, Lorenz; Hansmann, Martin-Leo; Hartmann, Sylvia.
Afiliação
  • Bein J; Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
  • Thurner L; Department of Internal Medicine I and José Carreras Center for Immuno- and Gene Therapy, Saarland University Medical School, Homburg/Saar, Germany.
  • Hansmann ML; Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
  • Hartmann S; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.
Am J Hematol ; 95(12): 1495-1502, 2020 12.
Article em En | MEDLINE | ID: mdl-32815561
ABSTRACT
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a subtype of Hodgkin lymphoma with a preserved B-cell phenotype and follicular T helper (TFH ) cells rosetting around the tumor cells, the lymphocyte-predominant (LP) cells. As we recently described reactivity of the B-cell receptors of LP cells of some NLPHL cases with Moraxella spp. proteins, we hypothesized that LP cells could present peptides to rosetting T cells in a major histocompatibility complex class II (MHCII)-bound manner. Rosetting PD1+ T cells were present in the majority of NLPHL cases, both in typical (17/20) and variant patterns (16/19). In most cases, T-cell rosettes were CD69+ (typical NLPHL, 17/20; NLPHL variant, 14/19). Furthermore, both MHCII alpha and beta chains were expressed in the LP cells in 23/39 NLPHL. Proximity ligation assay and confocal laser imaging demonstrated interaction of the MHCII beta chain expressed by the LP cells and the T-cell receptor alpha chain expressed by rosetting T cells. We thus conclude that rosetting T cells in NLPHL express markers that are encountered after antigenic exposure, that MHCII is expressed by the LP cells, and that LP cells interact with rosetting T cells in an immunological synapse in a subset of cases. As they likely receive growth stimulatory signals in this way, blockade of this interaction, for example, by PD1-directed checkpoint inhibitors, could be a treatment option in a subset of cases in the future.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfócitos B / Antígenos de Diferenciação / Infecções por Moraxellaceae / Sinapses Imunológicas / Moraxella Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfócitos B / Antígenos de Diferenciação / Infecções por Moraxellaceae / Sinapses Imunológicas / Moraxella Idioma: En Ano de publicação: 2020 Tipo de documento: Article